News & Events

All the latest news and events from PhoreMost

PhoreMost and Oxford Biomedica enter gene therapy discovery collaboration
9th November 2020

PhoreMost and Oxford Biomedica enter gene therapy discovery collaboration

Collaboration to develop next-generation CAR-T cell therapies with improved efficacy and durability PhoreMost’s SITESEEKER platform will identify active peptides to be deployed within Oxford Biomedica’s LentiVector delivery system Cambridge and Oxford, UK, 09 November 2020 : PhoreMost Limited, the UK-based biopharmaceutical company dedicated to developing drugs against intractable disease tar …

PhoreMost named ‘Biotech Company of the Year’ at Cambridge Independent Science and Technology Awards 2019
31st October 2019

PhoreMost named ‘Biotech Company of the Year’ at Cambridge Independent Science and Technology Awards 2019

PhoreMost appoints Dr Lorenz Mayr as Non-Executive Director
15th July 2019

PhoreMost appoints Dr Lorenz Mayr as Non-Executive Director

PhoreMost and inStem enter structural biology alliance
8th July 2019

PhoreMost and inStem enter structural biology alliance

PhoreMost and C4X Discovery announce neurodegeneration focused drug discovery collaboration
25th June 2019

PhoreMost and C4X Discovery announce neurodegeneration focused drug discovery collaboration

PhoreMost and Ligand Subsidiary Vernalis Limited Announce Drug Discovery Collaboration for Novel Oncology Target
12th June 2019

PhoreMost and Ligand Subsidiary Vernalis Limited Announce Drug Discovery Collaboration for Novel Oncology Target

PhoreMost and o2h discovery collaborate to progress first-in-class drug discovery programs
21st June 2018

PhoreMost and o2h discovery collaborate to progress first-in-class drug discovery programs

No events currently available